HMGB1 has been shown to be an independent prognostic factor for patients with squamouscell carcinoma of the head and neck [12], and its overexpression also plays a role in the progression of nasopharyngeal carcinoma (NPC) and is correlated with a poor clinical outcome [11]. Here, HMGB1 is linked to nasopharyngeal carcinoma.